Generics & Supergenerics

The change in the generics industry competitive landscape is driving the evolution of traditional business operating models. Companies are seeking further competitive advantage through innovation, differentiation and enhanced quality of products, striving for smarter, more profitable business models, cost effectiveness and faster routes to market. Traditional pharmaceutical innovators are coupling with generic manufacturers to better serve the healthcare sector with more companies like Novartis launching or acquiring generics arms to their businesses.

With more than 30 drugs coming off-patent in the next 3-5 years, this will open up serious competition from the generics alternatives. Pharmaceutical innovators strive to protect their intellectual property and product brands by extending patents, whilst generic producers fight to occupy the new space in the market, capitalising on the new opportunities. As a result, the generics space is pitched for fundamental growth with revenues reaching more than $84bn by 2010.

With this back-drop, SMi announces the 12th annual Generics & Super-generics conference. Holistic and controversial in its theme, the 2009 conference agenda aims to tackle the business and profitability issues and challenges faced by the generic manufacturers, but at the same time offering patent protection, intellectual property and patentability advice to the pharmaceutical innovators.

Speakers are the generics players - presenting case studies & evaluating business models; key consultants, analysts and external experts - outlining policy, regulation and providing strategic tips around the challenges that this market faces.

Topics that will be covered include:

• Intellectual Property protection: patentability, patent extensions and exclusivity
• Ever-greening strategies
• Protection strategies whether you are branded or generic
• Blockbuster drugs due for patent expiration come 2012
• Profitability models
• Emerging markets and improved generics
• The changing generics business model in the competitive climate
• Market expansion strategies
• Biosimilars: Regulatory, scientific and commercial aspects
• Innovation and differentiation
• Ways to capitalise on patent and product brands
• Patent busting strategies
• Reduction of portfolio risk
• Patent Life Cycle Management

Why should you attend this event?

The changing landscape of the generics market means that more pharmaceutical companies are entering the generics space. Existing manufacturers need to work harder and smarter to protect their market share.

• Learn how to capitalizing on close to patent expiration of branded drugs, extending the life cycle of your products
• Reduce portfolio risk by developing re-formulations and extended uses for existing products
• Tackle intellectual property and brand protection
• Develop market growth expansion strategies
• Evaluate existing business profitability models in the generics market
• Differentiate yourselves from your competitors
• Formulate patent busting strategies
• Weigh up emerging market opportunities
• Attend the in-depth post-conference workshops on intellectual property protection and patentability and patent busting options.

There will also be ample time for networking with peers during lunch and all of the refreshment breaks.

Hear keynote addresses from:

• Alexandre Williams, Director of Business Development, Ethypharm
• Rahul Garella, Senior VP - EU Business, Glenmark Generics

Our expert speaker line-up also includes:

• Milena Izmirlieva, Project Manager, IHS Global Insights
• Sune Larsen, Case Handler, European Commission - DG Competition
• Aleksandar Danilovski, Senior Director, Head of API R&D, PLIVA
• Professor Adrian Towse, Director, Office of Health Economics 
• Murray Duchame, Chief Science Officer, Cetero Research
• Dr Duncan Curley, Director, Innovate Legal
• Martin Paltnoi, CEO, MPA Business Services
• Brian Tempest, Former CEO, Ranbaxy Laboratories
• Howard Rosenberg, Scientific Advisor, Frommer, Lawrence and Haug LLP

Who should attend?

From pharmaceutical innovators:

• Patent, Directors and Managers
• Directors of Intellectual Property
• Brand Directors and Managers
• Product Directors and Managers
• Directors of Business Development

From generics manufacturers:

• Business Development leaders
• Presidents and CEOs
• Commercial Directors
• Operations Directors
• Driectors of R&D
• Managing Directors

All other generics industry stakeholders

• Patent attorneys
• Intellectual Property experts
• Branding specialists

Venue details

. Crowne Plaza St James London   . 45-51 Buckingham Gate London SW1E 6AF   Tel: +44 (0) 207 834 6655 Fax: +44 (0) 207 6307   www.london.crowneplaza.com

.  .

Crowne Plaza St James London is a traditional deluxe hotel right in the heart of the city, perfectly situated for all your business and leisure needs.  In the heart of Westminster, it is just a stones throw away from Buckingham Palace, The Houses of Parliament, the London Eye and Victoria Station.

The hotel boasts three excellent restaurants. Bistro 51 with British and European cuisine, the Michelin Starred Indian restaurant Quilon serving south coastal Indian food and Bank Westminster with a modern British menu.

A beautiful, award-winning, courtyard garden surrounds the Victorian buildings of the Crowne Plaza London St James - a peaceful oasis in the centre of London.
 
Nearest train stations:
• Victoria Station, 7 minutes’ walk
• Waterloo Station, 10 minutes by car

Underground stations
• St James’s Park, 5 minutes’ walk (District and Circle lines)
• Victoria Station, 7 minutes' walk (Victoria, District and Circle lines)

From St. James's Park Underground Station to the Hotel

Take the main St James’s Park exit and turn left into Petty France Street.
Continue Straight down for 200 yards and at the end turn left into Buckingham Gate

SMi discounted rates include Continental Breakfast & VAT
£ 205.63 / Standard room / night for single occupancy
£ 229.13 Executive  room / night for single occupancy

Book your accommodation at SMi discounted rates by calling us on +44 (0)870 9090 713, sending a fax to +44 (0)870 9090 714 or emailing hotels@smi-online.co.uk.
 

For content or conference programme enquiries, please contact Ciaran Larkin on +44 (0) 20 7827 6038 or email clarkin@smi-online.co.uk

SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company's marketing strategy.  Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call: Alia Malick, SMi Sponsorship on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk @smi-online.co.uk